Fig 1 - uploaded by Nihal Thomas
Content may be subject to copyright.
Computed tomography scan of the abdomen showing bulky pancreas with dilated main pancreatic duct, intraparenchymal calcification and intraductal calculi (arrow). 

Computed tomography scan of the abdomen showing bulky pancreas with dilated main pancreatic duct, intraparenchymal calcification and intraductal calculi (arrow). 

Source publication
Article
Full-text available
Background: The association between pancreatic disease and primary hyperparathyroidism (PHPT) is controversial. We attempt to suggest a causal correlation and characterize the nature of pancreatic disease in PHPT. Methods: This study is a retrospective review of the medical records of patients who were diagnosed with PHPT and presented with pancrea...

Contexts in source publication

Context 1
... remains uncommon and pancreatic disease with PHPT extremely rare. Much later publications dealing with parathyroid disease are hesitant to attribute a direct causal linkage between the two and underplay the association. After the 1980s various studies from developed countries have shown the association of pancreatitis with PHPT to range from 3.2 to 5.6%. 7–9 Data from other developing countries show this association in approximately 2.5% of patients. 10,11 One centre from the northern India has reported that in 6.8% of patients with PHPT, the disease was initially suspected because of unexplained pancreatic disease. 12 As pancreatic disease remains an important initial clinical presentation in the present setting, we attempt to characterize it in patients with PHPT in terms of their clinical presentation, biochemistry and imaging parameters. This study is a retrospective review of the medical records of 13 patients of a total of 101 PHPT patients who presented with pancreatic disease at Christian Medical College, Vellore between 1 May 2000 and 30 May 2005. The medical records were reviewed for patient characteristics and clinical details. Biochemical records of all 101 patients with PHPT were retrieved from the computerized hospital information processing system. The patients were divided into group 1 having PHPT with pancreatic disease and group 2 having PHPT without pancreatic disease. The diagnosis of pancreatitis was confirmed by detection of an increased serum amylase (>3 times the normal) and/or increased lipase levels in the presence of upper abdominal pain. The diagnosis was confirmed by the presence of abnormalities on pancreatic imaging. Other aetiologies of pancreatic disease including gall bladder disease, microliths in bile, hypertriglyceridaemia, history of alcohol intake, medications and abdominal trauma were sought. The biochemical diagnosis of PHPT was made when persistent increased calcium levels above the upper limit of normal was associated with an increased circulating immune reactive intact parathyroid hormone levels. The calcium values were corrected for the serum albumin values and the results were expressed as corrected calcium levels. Detailed radiological reports were obtained from the picture archiving and communicating system (General Electric– Picture Archiving and Communicating System) and reviewed with a radiologist. Data were analysed using the Statistical Program for Social Sciences ( SPSS version 11.0 for Windows; SPSS , Chicago, IL, USA). Descriptive statistics were used in most of the reviews as the patient number was small. Thirteen patients were identified from among a cohort of 101 ( ; 13%) patients with confirmed PHPT who had clinical or ana- tomical evidence of pancreatic disease over a period of 5 years in our hospital. During the same period, there were 1284 admissions for pancreatic disease out of 302 883 inpatient admissions. In 12 patients ( ; 12%) pancreatic disease was the presenting symptom and the initial clinical indication to make an assessment for parathyroid disease. One patient had pancreatic involvement in addition to severe bone disease as the presenting symptom. The patients ranged from 22 to 52 years in age with a median age of 37 years. The median age of patients in group 2 was 43 years. There were 9 (69%) men and 4 (31%) women among patients in group 1. Among patients in group 2 there were 38 (43%) men and 50 (57%) women. The common presentation of pancreatic disease was either recurrent episodes of upper abdominal pain seen in 6 (46%) of the 13 patients or a single episode of acute pancreatitis seen in another 6 (46%) of these patients. One of the patients mentioned had an episode of life-threatening acute pancreatitis requiring surgical intervention. One patient (8%) presented with a painless chronic pancreatitis characterized by malabsorption and secondary dia- betes. The duration of symptoms before the diagnosis of PHPT was made ranged from a few days to 22 years. The median period before the diagnosis of PHPT was entertained was 6 months. Six (46%) of the patients had more than five episodes of pain, requiring an average of four hospital admissions for treatment of pain before surgery could be undertaken for the parathyroid adenoma. Significant weight loss was seen in five (38%) of the patients. However, malabsorption was documented in only one patient (8%). Other causes of pancreatitis were sought in all patients. Nine patients (69%) had a normal gall bladder on ultrasound imaging, whereas three (23%) had echogenic sludge in the gall bladder and in one (8%) patient the gall bladder could not be observed because of prior cholecystectomy. One patient (8%) had history of chronic alcohol dependence. Symptomatic nephrolithiasis was seen in 6 (46%) patients in group 1. Of the six patients with renal stones, one (8%) patient had bilateral stone disease, one (8%) had unilateral stone disease and four (30.8%) had nephrocalcinosis. Two patients (15%) had a history of bone pains whereas three (23.1%) had proximal muscle weakness. Two (15%) patients had a history of pathological fractures and one (8%) patient had a palpable mass in the neck. Among patients in group 2, bone disease was present in 60% of patients with 28% having severe bone pains, 31% had proximal muscle weakness, 37% had pathological fractures, 26% had radiological osteitis fibrosa cystica (OFC), 13% had palpable OFC and 3% had spinal deformities at the time of presentation. Symptomatic renal stones were seen in 36% patients, including 16% with the presence of renal parenchymal calcification. A palpable neck nodule was felt in 11% of patients. The median duration of symptoms in group 2 patients before the diagnosis of PHPT was 24 months. Details of the biochemical profiles of groups 1 and 2 are shown in Table 1. The pancreatic anatomy of group 1 patients was characterized with either ultrasound or computed tomography (Fig. 1). The details are provided in Table 2. Of the eight patients who underwent ultrasound of the neck, four (50%) had detectable lesions on the scan. A 99 technetium sesta- mibi scan was carried out on all patients. Eleven of them had unequivocal uptake that was suggestive of a single adenoma and two had a doubtful uptake. Surgical details are shown in Table 2. No postoperative complications were observed except for transient hypocalcaemia in two of the patients operated on. The association of primary hyperthyroidism with pancreatic disease has been controversial because of the rarity of the association in contemporary published work in developed ...
Context 2
... pancreatic anatomy of group 1 patients was characterized with either ultrasound or computed tomography (Fig. 1). The details are provided in Table ...

Citations

... A, Serum calcium levels in PHPT and non-PHPTpancreatitis patients modified from Bhadada et al 13 (n = 9 patients per group). B, Serum calcium levels in PHPT-pancreatitis and PHPT-non-pancreatitis patients as reported by Jacob et al, 21 Khoo et al, 12 Carnaille et al, 16 and Felderbauer et al. 11,22 PHPT indicates primary hyperparathyroidism. Bai ...
Article
Full-text available
The association between primary hyperparathyroidism (PHPT) and acute or chronic pancreatitis is controversial. For this reason, we conducted a review of the literature over the past 30 years to explore the relationship between these 2 disorders. Ten retrospective studies each with >50 patients diagnosed with PHPT were identified. With the notable exception of 2 studies, the rate of pancreatitis among patients with PHPT was higher than that reported in general among hospitalized patients without PHPT. A higher serum calcium level may contribute to pancreatitis in these cases, along with additional genetic or environmental insults. Hypercalcemia may predispose the pancreatic acinar cell to abnormal, sustained calcium levels, lead to premature pancreatic protease activation, and pancreatitis. Although there was only short-term follow-up, most reports cited that definitive treatment of PHPT by parathyroidectomy led to the resolution of pancreatitis attacks. The published cohorts of patients with PHPT and pancreatitis are subject to bias, because serum calcium screening was not universally performed among all control nonpancreatitis patients to evaluate for PHPT. However, the pooled clinical and experimental data suggest an association between PHPT and pancreatitis and implicate hypercalcemia. For clinicians, it is important to recognize pancreatitis in patients with PHPT and, conversely, to consider PHPT by checking serum calcium levels in patients, who present with an unexplained pancreatitis.
Article
Background: Elastase-1 is a proteolytic enzyme secreted by pancreatic acinar cells, and measurements of the concentration this enzyme are used to evaluate pancreatic exocrine function. We aimed to determine whether pancreatic exocrine function declines due to chronic hypercalcemia by measuring fecal elastase levels. Methods: 75 patients with primary hyperparathyroidism (18 men and 47 women) and 30 healthy subjects (11 men and 19 women) participated in this study. Renal function tests, lipid parameters, bone mineral density, and serum calcium, phosphorus, vitamin D, parathormone, glucose, and thyroid stimulating hormone levels as well as fecal elastase concentrations, were determined in these patients and controls. Results: The mean fecal elastase level was 335.3 ± 181.4 μg/g in the PHPT group and 317.4 ± 157.3 μg/g in the control group. There was no significant difference in fecal elastase levels between the two groups (p = 0.5). Conclusions: Chronic hypercalcemia in primary hyperparathyroidism did not decrease the fecal elastase level, which is an indirect indicator of chronic pancreatitis; therefore, chronic hypercalcemia in PHPT may not cause chronic pancreatitis.
Article
Human ficolin-2 is an important lectin complement pathway activator that is secreted from liver cells and has been implicated as an anti-infection innate immune molecule. However, the role of ficolin-2 protein and its dynamic changes over the course of and in the prognosis of chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC) remain unclear. In this study, we analyzed ficolin-2 protein expression in a cohort of individuals with CHB infection, HCC and cirrhosis. A sandwich enzyme-linked immunosorbent assay (ELISA) method was used to measure serum ficolin-2 concentrations. Ficolin-2 expression in liver tissues was detected by immunohistochemical staining. Serum ficolin-2 concentrations in CHB patients were significantly higher than in healthy controls and HBV carriers. After 48 weeks of routine amelioration liver function treatment, serum ficolin-2 concentrations decreased and were positively correlated with favorable alanine aminotransferase (ALT), HBV DNA and HBeAg-seroconversion outcomes. Interestingly, we observed much lower expression of serum and intrahepatic ficolin-2 in HCC and cirrhosis compared with healthy controls. Our findings suggest that serum and intrahepatic ficolin-2 levels may be considered one of the indicators for the response of chronic HBV infection, HCC and cirrhosis.
Article
The aim of this paper is to report an atypical presentation of MEN2A, in a patient carrying the C634R mutation of the RET-protooncogene. A 41-year-old Tunisian woman was admitted to our department with newly diagnosed hyperglycemia. She had a history of bilateral urinary stone recurrence, managed successfully on two occasions. On physical examination a thyroid node of 1cm on the left side was found. Laboratory evaluation and imaging findings confirmed the diagnosis of primary hyperparathyroidism. During cervicotomy, the parathyroid adenoma was resected and the thyroid node was suspected to be a carcinoma. Total thyroidectomy, with appropriate neck nodal resection, was performed. Histological examination confirmed the diagnosis of parathyroid adenoma and revealed a multifocal and bilateral medullary carcinoma. These findings led to the diagnosis of multiple endocrine neoplasia. DNA-analysis demonstrated a germline Cys634Arg mutation in the RET-protooncogene. During the postoperative follow-up, blood pressure as well as the level of urinary methoxylated metabolites increased progressively. Imaging findings were compatible with the diagnosis of bilateral pheochromocytoma. In conclusion, this case report of MEN 2A linked to a 634 RET mutation was peculiar by its revelation mode (1) hyperparathyroidism moreover linked to an adenoma and (2) associated with diabetes, mechanisms of which are probably multifactorial (familial type 2 diabetes, hypercalcemia, catecholamines excess).